| Abstract [eng] |
Background: Ischemic heart disease is the single most common cause of death worldwide. The term includes acute coronary syndromes. To improve survival rates, time is a crucial factor. Latter highlighting the relevance of the prehospital phase. Objective: The aim of this research is to provide an overview of current standards, as well as ongoing research and its future implications in the prehospital care of patients with acute coronary syndromes. Methods: A narrative literature review was conducted. Regarding the current standards of care, society guidelines were referred to. For the part of ongoing research, terms were created and searched for in the PubMed database. Subsequently, the results were filtered by various criteria to match the structure of this review. Discussion: Regarding prehospital logistics of care, delays attributable to various parties in the prehospital setting, as well as measures to shorten the prehospital time have been assessed. The diagnosis of acute coronary syndromes in the preclinical setting is traditionally based on signs and symptoms, complemented by12-lead electrocardiogram acquisition and analysis. Cardiac biomarkers for prehospital risk stratification are a novelty and their implementation is a matter of ongoing research. While most principles of prehospital treatment of acute coronary syndromes are based on society guidelines, telemedical advancements can support paramedics and emergency medical physicians on scene. Conclusion: While still a novelty, prehospital cardiac biomarkers could help to improve diagnostic accuracy, reduce delays, and increase cost effectiveness. Hereby enhancing the efficiency of prehospital logistics of care and guiding preclinical treatment. However, further research and acquisition of high-quality evidence is still required. |
